Physician profile

Raymond J Holmes

Vascular Surgery · Clifton, NJ

NPI 1699771220

$13,340.14

in general payments reported to CMS, 2019-2025

34 companies · $1,825 in 2025

The $1,825 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).

See the full distribution for Vascular Surgery

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$6,094.48

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Silk Road Medical, INC. $2,065.13 2019-2024 Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent
Endologix LLC $1,939.85 2019-2024 Alto Abdominal Stent Graft System
Inari Medical, INC. $1,266.23 2019-2024 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Penumbra, INC. $1,114.11 2019-2025 Indigo System, Ruby Coil
Medtronic, INC. $1,070.00 2021-2025 Hawkone, Endurant Iis, Heli-Fx Endoanchor System
W. L. Gore & Associates, INC. $672.30 2021-2025 Gore Viabahn Vbx Balloon Expandable Endo
Bolton Medical INC $618.78 2022-2025 Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System
Bard Peripheral Vascular, INC. $612.03 2020-2024 Venclose Maven Catheter, Venovo
Medtronic Vascular, INC. $468.42 2019-2020
Convatec INC. $418.29 2024
Cook Medical LLC $371.17 2022-2025 Zenith Alpha, Cook
Cardiovascular Systems INC. $340.51 2019-2022
Boston Scientific Corporation $314.50 2023-2025 Enroute Transcarotid Neuroprotection System, General - Non-Vascular Intervention, Eluvia
Cvrx, INC. $203.34 2023-2025 Barostim Neo System
Abbott Laboratories $191.67 2019
Show all 34 companies
CompanyGeneral paymentsYearsTop products
Smith+Nephew, INC. $191.53 2019-2021
Angiodynamics, INC. $185.55 2024 Auryon Laser System 100-120 Vac
Tactile Systems Technology INC $185.07 2023-2024 Flexitouch Plus, Entre Plus
Ekos Corporation $160.08 2019
Acera Surgical, INC. $153.00 2025 Restrata Wound Matrix
Sanara Medtech INC. $150.00 2025 Celleraterx
Allergan, INC. $122.12 2019
Kci USA, INC. $83.55 2019
Stryker Corporation $77.19 2025 Flowtriever, Clottriever Bold Catheter
Janssen Pharmaceuticals, INC $74.54 2020-2022
Davol INC. $67.88 2021
Lemaitre Vascular, INC. $46.95 2022-2025 Artegraft Vascular Graft
Atricure, INC. $35.81 2019
Pfizer INC. $32.86 2023-2025
Kerecis Limited $30.18 2025 Kerecis Surgiclose, Kerecis Graftguide
Solventum Corporation $27.62 2025 Prevena
Musculoskeletal Transplant Foundation INC. $17.62 2025
Ethicon US, LLC $17.12 2019
Terumo Medical Corporation $15.14 2025 Angio-Seal

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Raymond J Holmes

$13,340.14

in general payments reported 2019-2025

Years
2019-2025
Top company
Silk Road Medical, INC.
Context
The $1,825 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).

https://glasscript.com/doctor/30992/raymond-j-holmes

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.